206 related articles for article (PubMed ID: 33249558)
1. Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A).
Kim YR; Yi M; Cho SA; Kim WY; Min J; Shin JG; Lee SJ
Ann Hum Genet; 2021 Mar; 85(2):80-91. PubMed ID: 33249558
[TBL] [Abstract][Full Text] [Related]
2. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.
Zhang W; Colman RW
Blood; 2007 Sep; 110(5):1475-82. PubMed ID: 17392505
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions.
Coenen DM; Heinzmann ACA; Oggero S; Albers HJ; Nagy M; Hagué P; Kuijpers MJE; Vanderwinden JM; van der Meer AD; Perretti M; Koenen RR; Cosemans JMEM
Cells; 2021 Aug; 10(8):. PubMed ID: 34440764
[TBL] [Abstract][Full Text] [Related]
4. A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium.
Sucharov CC; Nakano SJ; Slavov D; Schwisow JA; Rodriguez E; Nunley K; Medway A; Stafford N; Nelson P; McKinsey TA; Movsesian M; Minobe W; Carroll IA; Taylor MRG; Bristow MR
J Am Coll Cardiol; 2019 Mar; 73(10):1173-1184. PubMed ID: 30871701
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets.
Hunter RW; Mackintosh C; Hers I
J Biol Chem; 2009 May; 284(18):12339-48. PubMed ID: 19261611
[TBL] [Abstract][Full Text] [Related]
6. Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium.
Hambleton R; Krall J; Tikishvili E; Honeggar M; Ahmad F; Manganiello VC; Movsesian MA
J Biol Chem; 2005 Nov; 280(47):39168-74. PubMed ID: 16172121
[TBL] [Abstract][Full Text] [Related]
7. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice.
Sun B; Li H; Shakur Y; Hensley J; Hockman S; Kambayashi J; Manganiello VC; Liu Y
Cell Signal; 2007 Aug; 19(8):1765-71. PubMed ID: 17482796
[TBL] [Abstract][Full Text] [Related]
9. Platelet cyclic adenosine monophosphate phosphodiesterases: targets for regulating platelet-related thrombosis.
Colman RW
Semin Thromb Hemost; 2004 Aug; 30(4):451-60. PubMed ID: 15354266
[TBL] [Abstract][Full Text] [Related]
10. cUMP hydrolysis by PDE3A.
Berrisch S; Ostermeyer J; Kaever V; Kälble S; Hilfiker-Kleiner D; Seifert R; Schneider EH
Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):269-280. PubMed ID: 27975297
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.
Penmatsa H; Zhang W; Yarlagadda S; Li C; Conoley VG; Yue J; Bahouth SW; Buddington RK; Zhang G; Nelson DJ; Sonecha MD; Manganiello V; Wine JJ; Naren AP
Mol Biol Cell; 2010 Mar; 21(6):1097-110. PubMed ID: 20089840
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase.
Dünnes S; Voussen B; Aue A; Groneberg K; Nikolaev V; Groneberg D; Friebe A
Pflugers Arch; 2018 Apr; 470(4):693-702. PubMed ID: 29294149
[TBL] [Abstract][Full Text] [Related]
13. Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.
Ahmad F; Shen W; Vandeput F; Szabo-Fresnais N; Krall J; Degerman E; Goetz F; Klussmann E; Movsesian M; Manganiello V
J Biol Chem; 2015 Mar; 290(11):6763-76. PubMed ID: 25593322
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins.
Begum N; Hockman S; Manganiello VC
J Biol Chem; 2011 Jul; 286(29):26238-49. PubMed ID: 21632535
[TBL] [Abstract][Full Text] [Related]
15. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
Murthy KS; Zhou H; Makhlouf GM
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336
[TBL] [Abstract][Full Text] [Related]
16. Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.
Cheung PP; Yu L; Zhang H; Colman RW
Arch Biochem Biophys; 1998 Dec; 360(1):99-104. PubMed ID: 9826434
[TBL] [Abstract][Full Text] [Related]
17. Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
Ercu M; Mücke MB; Pallien T; Markó L; Sholokh A; Schächterle C; Aydin A; Kidd A; Walter S; Esmati Y; McMurray BJ; Lato DF; Yumi Sunaga-Franze D; Dierks PH; Flores BIM; Walker-Gray R; Gong M; Merticariu C; Zühlke K; Russwurm M; Liu T; Batolomaeus TUP; Pautz S; Schelenz S; Taube M; Napieczynska H; Heuser A; Eichhorst J; Lehmann M; Miller DC; Diecke S; Qadri F; Popova E; Langanki R; Movsesian MA; Herberg FW; Forslund SK; Müller DN; Borodina T; Maass PG; Bähring S; Hübner N; Bader M; Klussmann E
Circulation; 2022 Dec; 146(23):1758-1778. PubMed ID: 36259389
[TBL] [Abstract][Full Text] [Related]
18. 3'5'-cyclic adenosine monophosphate-dependent up-regulation of phosphodiesterase type 3A in porcine cumulus cells.
Sasseville M; Côté N; Vigneault C; Guillemette C; Richard FJ
Endocrinology; 2007 Apr; 148(4):1858-67. PubMed ID: 17218408
[TBL] [Abstract][Full Text] [Related]
19. A nonhydrolyzable reactive cAMP analogue, (S(p))-8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic S-(methyl)monophosphorothioate, irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase at micromolar concentrations.
Hung SH; Madhusoodanan KS; Boyd RL; Baldwin JL; Colman RF; Colman RW
Biochemistry; 2002 Mar; 41(9):2962-9. PubMed ID: 11863434
[TBL] [Abstract][Full Text] [Related]
20. Effects of phosphodiesterase 3A modulation on murine cerebral microhemorrhages.
Sumbria RK; Vasilevko V; Grigoryan MM; Paganini-Hill A; Kim R; Cribbs DH; Fisher MJ
J Neuroinflammation; 2017 Jun; 14(1):114. PubMed ID: 28583195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]